Overview

Varenicline for Light Smokers

Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if varenicline is effective in treating tobacco dependence in adults who smoke 5-10 cigarettes per day.
Phase:
Phase 4
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
Pfizer
Treatments:
Varenicline